1241 related articles for article (PubMed ID: 25999401)
1. Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Holmqvist F; Simon D; Steinberg BA; Hong SJ; Kowey PR; Reiffel JA; Naccarelli GV; Chang P; Gersh BJ; Peterson ED; Piccini JP;
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999401
[TBL] [Abstract][Full Text] [Related]
2. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Holmqvist F; Guan N; Zhu Z; Kowey PR; Allen LA; Fonarow GC; Hylek EM; Mahaffey KW; Freeman JV; Chang P; Holmes DN; Peterson ED; Piccini JP; Gersh BJ;
Am Heart J; 2015 May; 169(5):647-654.e2. PubMed ID: 25965712
[TBL] [Abstract][Full Text] [Related]
3. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP
Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822
[TBL] [Abstract][Full Text] [Related]
5. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
Steinberg BA; Kim S; Piccini JP; Fonarow GC; Lopes RD; Thomas L; Ezekowitz MD; Ansell J; Kowey P; Singer DE; Gersh B; Mahaffey KW; Hylek E; Go AS; Chang P; Peterson ED;
Circulation; 2013 Aug; 128(7):721-8. PubMed ID: 23861512
[TBL] [Abstract][Full Text] [Related]
6. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
[TBL] [Abstract][Full Text] [Related]
7. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
[TBL] [Abstract][Full Text] [Related]
8. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
[TBL] [Abstract][Full Text] [Related]
9. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
[TBL] [Abstract][Full Text] [Related]
12. Should surgical ablation for atrial fibrillation be performed in patients with a significantly enlarged left atrium?
Ad N; Henry L; Hunt S; Holmes SD
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):236-41. PubMed ID: 24183909
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF.
Steinberg BA; Holmes DN; Pieper K; Allen LA; Chan PS; Ezekowitz MD; Freeman JV; Fonarow GC; Gersh BJ; Hylek EM; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel J; Singer DE; Peterson ED; Piccini JP;
Circ Arrhythm Electrophysiol; 2020 May; 13(5):e007775. PubMed ID: 32298144
[TBL] [Abstract][Full Text] [Related]
14. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
Pokushalov E; Romanov A; De Melis M; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):754-60. PubMed ID: 23748210
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial.
Kaitani K; Inoue K; Kobori A; Nakazawa Y; Ozawa T; Kurotobi T; Morishima I; Miura F; Watanabe T; Masuda M; Naito M; Fujimoto H; Nishida T; Furukawa Y; Shirayama T; Tanaka M; Okajima K; Yao T; Egami Y; Satomi K; Noda T; Miyamoto K; Haruna T; Kawaji T; Yoshizawa T; Toyota T; Yahata M; Nakai K; Sugiyama H; Higashi Y; Ito M; Horie M; Kusano KF; Shimizu W; Kamakura S; Morimoto T; Kimura T; Shizuta S;
Eur Heart J; 2016 Feb; 37(7):610-8. PubMed ID: 26417061
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death.
Hunter RJ; McCready J; Diab I; Page SP; Finlay M; Richmond L; French A; Earley MJ; Sporton S; Jones M; Joseph JP; Bashir Y; Betts TR; Thomas G; Staniforth A; Lee G; Kistler P; Rajappan K; Chow A; Schilling RJ
Heart; 2012 Jan; 98(1):48-53. PubMed ID: 21930724
[TBL] [Abstract][Full Text] [Related]
17. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Steinberg BA; Peterson ED; Kim S; Thomas L; Gersh BJ; Fonarow GC; Kowey PR; Mahaffey KW; Sherwood MW; Chang P; Piccini JP; Ansell J;
Circulation; 2015 Feb; 131(5):488-94. PubMed ID: 25499873
[TBL] [Abstract][Full Text] [Related]
18. Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry.
Piccini JP; Simon DN; Steinberg BA; Thomas L; Allen LA; Fonarow GC; Gersh B; Hylek E; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Spertus JA; Peterson ED;
JAMA Cardiol; 2016 Jun; 1(3):282-91. PubMed ID: 27438106
[TBL] [Abstract][Full Text] [Related]
19. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Steinberg BA; Kim S; Thomas L; Fonarow GC; Hylek E; Ansell J; Go AS; Chang P; Kowey P; Gersh BJ; Mahaffey KW; Singer DE; Piccini JP; Peterson ED;
Circulation; 2014 May; 129(20):2005-12. PubMed ID: 24682387
[TBL] [Abstract][Full Text] [Related]
20. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA
Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]